- Filter:
- All
- News
- White Papers
- Articles
- Peer-reviewed Work
Evidence for Change: Impact of the CareKnowDo Program on Chronic Kidney Disease Self-Management
Tuesday, May 20, 2025
A discussion of a randomized controlled trial that explored the feasibility of a digital self-management support program for people living with chronic kidney disease.
Evidence for Change: The Impact of Nurse-Led Support for Caregivers of Children Taking Growth Hormone Treatment
Monday, May 12, 2025
Dr Debbie Cooke, our Head of Health Psychology in UK, discusses key findings of her recent paper on how a caregiver-focused support program improved growth hormone treatment adherence behaviors.
Addressing Reasons for Treatment Nonadherence in Autoimmune Conditions
Thursday, May 1, 2025
An overview of the intentional reasons for treatment nonadherence in people living with autoimmune conditions from Atlantis Health's Global Immunology Patient Study 2025—new insights into why some people choose not to adhere to prescribed treatment regimens.
High Rates of Treatment Nonadherence in Autoimmune Conditions
Tuesday, April 29, 2025
An overview of treatment adherence in people living with autoimmune conditions from Atlantis Health's Global Immunology Patient Study 2025—new insights into what does and does not impact rates of adherence.
Navigating the Autoimmune Journey: How Patient Psychosocial Factors Drive Engagement & Adherence
Tuesday, April 15, 2025
An overview of the patient experience across the autoimmune journey in Atlantis Health's Global Immunology Patient Study 2025—new insights into how patient psychosocial factors drive engagement and adherence.
Global Immunology Patient Study: Patient motivators to support treatment engagement
Tuesday, March 25, 2025
Overview of the key findings of Atlantis Health's Global Immunology Patient Study 2025—new insights into what motivates patients to take their treatment as prescribed.
Evidence for Change: Adherence & Persistence to GLP-1 Therapies
Tuesday, March 4, 2025
A discussion of a recent article that assessed real-world rates of adherence and persistence to GLP-1 (glucagon-like peptide-1 receptor agonists) therapies among adults living with obesity.
Case Study: Empowering people living with a rare disease
Thursday, February 27, 2025
Overview of an award-winning patient support program for people living with a rare disease.